Optimized glucuronidation of dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD

Mark E. Bunnage, Jane Burrows, Nick Clarke, Michele Coghlan, David Entwistle, David Fairman, Neil Feeder, Kim James, Rhys M. Jones, Nadia Laouar, Graham Lunn, Stuart Marshall, Sandra D. Newman, Sheena Patel, Matthew D. Selby, Fiona Spence, Emilio F. Stuart, Susan Summerhill, Michael A. Trevethick, Karen N. Wright, Michael Yeadon, David A. Price, Lyn H. Jones, Laura Hilton, Rachel Osborne, Amy S. Kenyon, Helen Baldock
  • MedChemComm, January 2011, Royal Society of Chemistry
  • DOI: 10.1039/c1md00140j
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Dr Lyn H Jones